Journal of Medicine Vol 4 - Amrita Institute of Medical Sciences and ...
Journal of Medicine Vol 4 - Amrita Institute of Medical Sciences and ...
Journal of Medicine Vol 4 - Amrita Institute of Medical Sciences and ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Amrita</strong> <strong>Journal</strong> <strong>of</strong> <strong>Medicine</strong><br />
Caution! Counterfeit <strong>Medicine</strong>s are on the Rise<br />
3. No medicine as labelled<br />
4. Inappropriate, but harmless ingredient(s) in place <strong>of</strong><br />
the labeled medicine(s)<br />
5. Inappropriate as well as potentially harmful<br />
ingredient(s) in place <strong>of</strong> the labeled medicine(s)<br />
6. Added - unlabeled harmless /potentially toxic / banned<br />
ingredients e.g., steroids with herbals<br />
7. Expired medicines repacked <strong>and</strong> relabeled<br />
8. <strong>Medicine</strong>s mimicking the original product in package<br />
design <strong>and</strong> label (fake packaging <strong>of</strong> legally manufactured<br />
medicine)<br />
THE POOR VICTIMS<br />
The entire human population are aggrieved <strong>and</strong> their<br />
lives are at risk. Many case <strong>of</strong> fatalities <strong>and</strong> morbidity<br />
have been reported from India. Category wise consequences<br />
are given below:<br />
1. Consumers, the primary victims:<br />
May be innocuous<br />
May result in permanent disability<br />
May be fatal<br />
2. Legitimate manufacturers:<br />
Undermine the confidence in their product<br />
Incur loss <strong>of</strong> sales<br />
3. Government:<br />
Fiscal loss <strong>of</strong> revenue to purchase<br />
spurious medicines<br />
Lead to collapse <strong>of</strong> health sector<br />
4. Health care pr<strong>of</strong>essionals:<br />
Loss <strong>of</strong> patient’s confidence in their services<br />
Loss <strong>of</strong> revenue<br />
THE CONCERN<br />
Initially counterfeiting was limited to comparatively<br />
expensive medicines. Today scenario has changed. Prescription,<br />
nonprescription, generic, br<strong>and</strong>ed,<br />
over-the-counter, life saving; all are being counterfeited.<br />
Many cases <strong>of</strong> fatalities have been reported from India<br />
due to the use <strong>of</strong> counterfeit medicines.<br />
FACILITATING FACTORS FOR COUNTERFEITING<br />
1. High dem<strong>and</strong> for medicines<br />
2. High cost <strong>of</strong> medicines <strong>and</strong> price variation<br />
3. Easy for transportation<br />
4. Scarcity <strong>and</strong> erratic supply <strong>of</strong> basic<br />
medicines<br />
5. Weak drug regulatory control in the<br />
fields <strong>of</strong> manufacture <strong>and</strong> marketing<br />
6. Poor socioeconomic status <strong>of</strong> the population - easy<br />
prey to corruption<br />
7. Lack <strong>of</strong> know how <strong>and</strong> lack <strong>of</strong> resources for quality<br />
assessment<br />
8. Lack <strong>of</strong> public awareness <strong>and</strong> political will<br />
9. Boost in the unscrupulous E- advertising <strong>and</strong> trading<br />
practices<br />
STRATEGIES TO COUNTER THE MENACE OF COUN-<br />
TERFEITING<br />
1. At the International Level:<br />
a. World Trade Organization’s General Agreement on<br />
Tariffs <strong>and</strong> Trade - Trade Related Aspects <strong>of</strong> Intellectual<br />
Property Rights Agreement 1994 (GATT -Trips<br />
Agreement 1994)<br />
All types <strong>of</strong> Intellectual property rights like patents,<br />
copyright <strong>and</strong> trademarks are protected globally by<br />
GATT- TRIPS Agreement 1994 signed by all member<br />
countries <strong>of</strong> the World Trade Organisation (WTO).<br />
This agreement covers all areas <strong>of</strong> business <strong>and</strong> sociey<br />
like pharmaceceuticals, s<strong>of</strong>tware, music, arts etc. The<br />
Agreement details all the rules related to enforcement<br />
<strong>of</strong> international laws in cases <strong>of</strong> fraud or<br />
counterfeiting like collection <strong>and</strong> documentation <strong>of</strong><br />
evidence, provisional measures to be adopted in such<br />
cases, penalties to be meted out etc. It is further<br />
agreed that that courts should have the right, under<br />
certain conditions, to order the disposal or destruction<br />
<strong>of</strong> pirated or counterfeit goods.<br />
b. International <strong>Medical</strong> Products Anti-Counterfeiting<br />
Taskforce (IMPACT)<br />
International <strong>Medical</strong> Products Anti-Counterfeiting<br />
Taskforce (IMPACT) has been set up in the United<br />
States <strong>of</strong> America <strong>and</strong> many European countries. Development<br />
<strong>of</strong> Global Anti- Counterfeit Task Force is<br />
on the anvil.<br />
c. Pharmacovigilance systems should be extended to<br />
include reporting <strong>of</strong> <strong>and</strong> investigating suspected cases<br />
<strong>of</strong> counterfeit medicines.<br />
d. Custom Offence<br />
1. Treat willful Counterfeiting <strong>of</strong> trademark as criminal<br />
<strong>of</strong>fence<br />
2. Enact <strong>and</strong> implement appropriate legislation to<br />
protect intellectual property right <strong>and</strong> to counter<br />
the movement <strong>of</strong> counterfeit <strong>and</strong> pirated goods<br />
across the border under the clause “custom <strong>of</strong>fence”<br />
14